June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Subthreshold diode micropulse laser photocoagulation versus low-fluence photodynamic therapy for the treatment of chronic central serous chorioretinopathy
Author Affiliations & Notes
  • Juan Giralt
    Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain
  • Ricardo Casaroli-Marano
    Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain
  • Anniken Burés-Jelstrup
    IMO, Barcelona, Spain
  • Rafael Navarro
    IMO, Barcelona, Spain
  • Jose Juan Martinez-Toldos
    Hospital General Universitario de Elche, Elche, Spain
  • Christian Fernandez-Martinez
    Hospital General Universitario de Elche, Elche, Spain
  • MSocorro Alforja
    Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain
  • Amanda Rey Torrente
    Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain
  • Footnotes
    Commercial Relationships Juan Giralt, None; Ricardo Casaroli-Marano, None; Anniken Burés-Jelstrup, None; Rafael Navarro, Novartis (C); Jose Juan Martinez-Toldos, None; Christian Fernandez-Martinez, None; MSocorro Alforja, None; Amanda Rey Torrente, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4140. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Juan Giralt, Ricardo Casaroli-Marano, Anniken Burés-Jelstrup, Rafael Navarro, Jose Juan Martinez-Toldos, Christian Fernandez-Martinez, MSocorro Alforja, Amanda Rey Torrente; Subthreshold diode micropulse laser photocoagulation versus low-fluence photodynamic therapy for the treatment of chronic central serous chorioretinopathy. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4140. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To compare clinical outcomes in patients with chronic central serous chorioretinopathy (cCSC), undergoing photocoagulation with subthreshold diode micropulse laser (SDM) versus low-fluence photodynamic therapy (PDT).

Methods: Retrospective, comparative, interventional case series. Thirty six eyes of 36 patients with no spontaneous resolution of neuroepithelial serous detachment confirmed by optical coherence tomography (OCT) and fluorescein angiography, after 6 months of the disease onset were included in this study, and underwent SDM or PDT. Best-corrected visual acuity (BCVA) and OCT were assessed prior to treatment and during the clinic follow-up.

Results: We evaluated 20 eyes in the SDM group and 16 eyes in the PDT group. All patients had an anatomical and functional improvement after treatment, except for two patients in the PDT group. In the SDM group, the average improvement of BCVA was 0.39±0.22 with central foveal thickness decrease of 210.1±77.6 μm. The retreatment rate was 0.45. The clinical follow-up was 13.5±6 months. In the PDT group, the average improvement of BCVA was 0.20±0.30 with central foveal thickness decrease of 102 ± 761μm. The retreatment rate was 0.19. The clinical follow-up was 20.4 ± 14.2 months.

Conclusions: These preliminary results show that SDM is more effective, inexpensive and save than low fluence PDT in the treatment of cCSC.

Keywords: 578 laser • 462 clinical (human) or epidemiologic studies: outcomes/complications • 688 retina  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×